Home » Trials Should Deal With Coverage Concerns Sooner, Study Says
Trials Should Deal With Coverage Concerns Sooner, Study Says
September 10, 2012
Drugmakers’ health economics and outcomes research teams must provide earlier input on clinical trials so the data they generate have a better chance of securing reimbursement for treatments following regulatory approval, a new study concludes.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor